Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-02-10

Clinical Trial Update: Selective AV Nodal Vagal Stimulation For Reduction of the Ventricular Rate During Atrial Fibrillation

View source ↗

Summary

The Cleveland Clinic-sponsored clinical trial evaluating selective AV nodal vagal stimulation to reduce ventricular rate during atrial fibrillation has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Cleveland Clinic | Conditions: Atrial Fibrillation | Status: WITHDRAWN